We note that our regulatory model has been trained in cancer cell lines (proliferating, often with mutations in the tumor suppressor p53 and oncogene MYC), which requires some caution when analyzing results concerning genes involved in cell cycle regulation and cellular proliferation. This evidence concerns the gene TP53 and cancer.